Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Abstract Background and aims In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly. At the onset of the COVID-19 pandemic, federa...
Saved in:
Main Authors: | Barrot H. Lambdin (Author), David Kan (Author), Alex H. Kral (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Availability of telehealth-based services at syringe services programs under the COVID-19 Public Health Emergency
by: Tyler S. Bartholomew, et al.
Published: (2023) -
Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs
by: Sheila V. Patel, et al.
Published: (2023) -
How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study
by: Barrot H. Lambdin, et al.
Published: (2023) -
Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes
by: Christopher F. Akiba, et al.
Published: (2024) -
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
by: Andrea Jakubowski, et al.
Published: (2022)